A Phase I Safety and Immunogenicity Dose Escalation Trial of Plague Vaccine, Flagellin/F1/V, In Healthy Adult Volunteers

Trial Profile

A Phase I Safety and Immunogenicity Dose Escalation Trial of Plague Vaccine, Flagellin/F1/V, In Healthy Adult Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Yersinia pestis vaccine (Primary)
  • Indications Plague; Yersinia infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 23 Oct 2014 Status changed from 'active, no longer recruiting' to 'completed' as reported by ClinicalTrials.gov record.
    • 15 Jan 2014 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov
    • 15 Aug 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top